Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NU7441 |
Trade Name | |
Synonyms | |
Drug Descriptions |
NU7441 inhibits DNA-PK, which may result in increased sensitivity of tumor cells to radiation and chemotherapy (PMID: 16707462, PMID: 31785810). |
DrugClasses | DNA_PK Inhibitor 9 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Doxorubicin + NU7441 | Doxorubicin NU7441 | 0 | 0 |
Etoposide + NU7441 | Etoposide NU7441 | 0 | 0 |
NU7441 | NU7441 | 0 | 0 |
NU7441 + Radiotherapy | NU7441 Radiotherapy | 0 | 0 |